Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

A.O. Siefker-Radtke; N. Matsubara; S.H. Park; R.A. Huddart; E.F. Burgess; M. Özgüroğlu; B.P. Valderrama; B. Laguerre; U. Basso; S. Triantos; S. Akapame; Y. Kean; K. Deprince; S. Mukhopadhyay; Y. Loriot; Patricia Bastick; Sanjeev Sewak; Ben Tran; Martin Pichler; Shahrokh Shariat; Sylvie Rottey; Peter Schatteman; Dirk Schrijvers; Vincent Verschaeve; Christof Vulsteke; Luiza Aleixo Barros Leite Ferreira; Pereira de Santana Gomes Andrea Juliana; Joao Antonio Junior; Sergio Azevedo; Diogo Bastos; Giuliano Borges; Aldo Dettino; Pires Luis Antonio; Murilo Luz; Suelen Martins; Jose Mauricio Mota; Joseane Toledo; Bernhard Eigl; Daygen Finch; Joel Gingerich; Haiying Dong; Jian Huang; Jie Jin; Hongming Pan; Zhongquan Sun; Ye Tian; Ben Wan; Bin Wu; Ting Xu; Wei Xue; Fangjian Zhou; Philippe Barthelemy; Delphine Borchiellini; Fabien Calcagno; Aurelien Carnot; Pierre Cornillon; Remy Delva; Sheik Emambux; Nadine Houede; Brigitte Laguerre; Géraldine Lauridant; Yohann Loriot; Hakim Mahammedi; Denis Maillet; Damien Pouessel; Guilhem Roubaud; Friederike Schlurmann-Constans; Diego Tosi; Sylvie Zanetta; Severine Banek; Susan Feyerabend; Mario Kramer; Guenther Niegisch; Philipp Nuhn; Marco Schnabel; Christian Wuelfing; Sofia Baka; Aristotelis Bamias; George Fountzilas; Harabolos Kalofonos; Konstantinos Karalis; Athanasios Kotsakis; Eleni Timotheadou; Laszlo Landherr; Laszlo Mangel; Avivit Pe’er; Meital Levratovsky; Umberto Basso; Nicola Battelli; Alessia Cavo; Ugo De Giorgi; Laura Doni; Luca Galli; Maria Olga Gigante; Valentina Guadalupi; Michele Maio; Laura Milesi; Franco Nolè; Giorgio Scagliotti; Giampaolo Tortora; THOR Cohort 2 Investigators

doi:10.1016/j.annonc.2023.10.003

Retour

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

Article de revue

Avec comité de lecture

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

A.O. Siefker-Radtke, N. Matsubara, S.H. Park, R.A. Huddart, E.F. Burgess, M. Özgüroğlu, B.P. Valderrama, B. Laguerre, U. Basso, S. Triantos, …

Annals of oncology, Vol.35(1), pp.107-117

01/01/2024

DOI: https://doi.org/10.1016/j.annonc.2023.10.003

PMID: 37871702

Indicateurs

1 Consultations de la notice

See more details

Détails

Titre: Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial
Créateurs - sans rôle: A.O. Siefker-Radtke
N. Matsubara
S.H. Park
R.A. Huddart
E.F. Burgess
M. Özgüroğlu
B.P. Valderrama
B. Laguerre
U. Basso
S. Triantos
S. Akapame
Y. Kean
K. Deprince
S. Mukhopadhyay
Y. Loriot
Patricia Bastick
Sanjeev Sewak
Ben Tran
Martin Pichler
Shahrokh Shariat
Sylvie Rottey
Peter Schatteman
Dirk Schrijvers
Vincent Verschaeve
Christof Vulsteke
Luiza Aleixo Barros Leite Ferreira
Pereira de Santana Gomes Andrea Juliana
Joao Antonio Junior
Sergio Azevedo
Diogo Bastos
Giuliano Borges
Aldo Dettino
Pires Luis Antonio
Murilo Luz
Suelen Martins
Jose Mauricio Mota
Joseane Toledo
Bernhard Eigl
Daygen Finch
Joel Gingerich
Haiying Dong
Jian Huang
Jie Jin
Hongming Pan
Zhongquan Sun
Ye Tian
Ben Wan
Bin Wu
Ting Xu
Wei Xue
Fangjian Zhou
Philippe Barthelemy
Delphine Borchiellini
Fabien Calcagno
Aurelien Carnot
Pierre Cornillon
Remy Delva
Sheik Emambux
Nadine Houede
Brigitte Laguerre
Géraldine Lauridant
Yohann Loriot
Hakim Mahammedi
Denis Maillet
Damien Pouessel
Guilhem Roubaud
Friederike Schlurmann-Constans
Diego Tosi
Sylvie Zanetta
Severine Banek
Susan Feyerabend
Mario Kramer
Guenther Niegisch
Philipp Nuhn
Marco Schnabel
Christian Wuelfing
Sofia Baka
Aristotelis Bamias
George Fountzilas
Harabolos Kalofonos
Konstantinos Karalis
Athanasios Kotsakis
Eleni Timotheadou
Laszlo Landherr
Laszlo Mangel
Avivit Pe’er
Meital Levratovsky
Umberto Basso
Nicola Battelli
Alessia Cavo
Ugo De Giorgi
Laura Doni
Luca Galli
Maria Olga Gigante
Valentina Guadalupi
Michele Maio
Laura Milesi
Franco Nolè
Giorgio Scagliotti
Giampaolo Tortora
THOR Cohort 2 Investigators
Détails de publication: Annals of oncology, Vol.35(1), pp.107-117
Nombre de pages: 11
Identifiants: 99140175009311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM
Langue: English
Type de ressource: Journal article